Skip to content
HowShorted

Emergent Biosolutions, Inc. short interest in 2023

In 2023, Emergent Biosolutions, Inc.'s disclosed short interest ran from 10.73% of shares outstanding on 13 Jan 2023 to 22.48% on 29 Dec 2023, a change of +11.75 percentage points. The year's high was 22.48% on 29 Dec 2023 and its low 10.73% on 13 Jan 2023, averaging 15.91% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.49 days on 29 Dec 2023. Full history: Emergent Biosolutions, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Emergent Biosolutions, Inc. in 2023

2023 in figures

Start of year
10.73% (13 Jan 2023)
End of year
22.48% (29 Dec 2023)
Change
+11.75 pp
High
22.48% (29 Dec 2023)
Low
10.73% (13 Jan 2023)
Average
15.91%
Highest days to cover
10.49 (29 Dec 2023)
SEC filings marked
9

Every report in 2023

Emergent Biosolutions, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202310.73%5.54results (8-K)
31 Jan 202311.27%8.32
15 Feb 202311.27%7.43
28 Feb 202311.14%2.75results (8-K)
15 Mar 202312.45%4.4910-K filed
31 Mar 202315.24%2.31
14 Apr 202314.42%3.39
28 Apr 202313.33%5.09
15 May 202312.58%4.26results (8-K), 10-Q filed
31 May 202313.44%6.45
15 Jun 202313.93%6.32
30 Jun 202315.30%3.69
14 Jul 202316.56%7.99
31 Jul 202317.40%5.68
15 Aug 202317.86%4.16results (8-K), 10-Q filed
31 Aug 202316.20%2.14
15 Sep 202318.27%2.81
29 Sep 202315.16%4.30
13 Oct 202317.31%6.06
31 Oct 202321.10%8.33
15 Nov 202320.81%6.86results (8-K)
30 Nov 202321.70%8.87
15 Dec 202321.83%6.6510-Q filed
29 Dec 202322.48%10.49

See also: Emergent Biosolutions, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.